AIMC
EW icon

Alley Investment Management Company’s Edwards Lifesciences EW Stock Holding History

Alley Investment Management Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,055
Closed -$242K – 80
2022
Q1 		$242K Buy
+2,055
New +$231K 0.04% 79

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alley Investment Management Company's EW Position: Q2 2022 in Review

Alley Investment Management Company sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 2,055 shares — an estimated $242K sold.

Alley Investment Management Company first reported a position in EW in Q1 2022 and held it in 1 quarter. The position peaked at $242K in Q1 2022. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Alley Investment Management Company reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Alley Investment Management Company sold 2,055 Edwards Lifesciences shares in Q2 2022, an estimated $242K.
  • Alley Investment Management Company first reported a position in Edwards Lifesciences in Q1 2022 and held it in 1 quarter.
  • Alley Investment Management Company's Edwards Lifesciences position peaked at $242K in Q1 2022.
  • 1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Alley Investment Management Company's 13F filing for Q2 2022, filed 5 Aug 2022.